Your session is about to expire
← Back to Search
Metformin vs. Birth Control Pills for Polycystic Ovary Syndrome (SHK002 Trial)
SHK002 Trial Summary
This trial will compare metformin to oral combined hormonal contraceptives in treating Polycystic Ovary Syndrome in women of later reproductive age, using the Polycystic Ovary Syndrome Questionnaire score as a proxy for patient satisfaction.
SHK002 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSHK002 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SHK002 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What do Oral combined hormonal contraceptives typically treat?
"Oral combined hormonal contraceptives are frequently employed to treat exercise-induced conditions. Additionally, the drug has therapeutic applications for type 1 diabetes mellitus, diabetic ketoacidosis, and polycystic ovary syndrome."
What criteria must one fulfill to be eligible for this experiment?
"Successful applicants to this medical trial must be aged between 40 and 49 years old with a diagnosis of polycystic ovaries. A total of 88 participants are being recruited for the experiment."
What other explorations have been conducted concerning the efficacy of Oral combined hormonal contraceptives?
"Currently, there are 170 trials being conducted on Oral combined hormonal contraceptives with 43 of them in Phase 3. Rockville, Maryland is one among the 1903 sites hosting these clinical trials; however many other locations exist throughout the country."
How many participants has this research recruited thus far?
"Affirmative. According to research posted on clinicaltrials.gov, this medical trial is currently recruiting patients who are able and willing to participate. Originally published on August 23rd 2021 with its last edit occurring October 31st 2022, the study aims to involve 88 people from a single location."
Are more participants needed to join this experiment?
"According to clinicaltrials.gov, this trial is still actively seeking patients for participation. It was first launched on August 23rd 2021 and its information has been updated as recently as October 31st 2022."
Is the age criteria for this research limited to those under 30 years?
"To be considered for this clinical trial, patients must be between 40 and 49 years old. For those younger than 18 or older than 65, there are 39 trials and 136 trials available respectively."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger